UB Paderborn / Katalog / Suche / in CDI

1 – 24 von 24

Sortiert nach

Real‐world application of plasmapheresis for neurological disease: Results from the Japan‐Plasmapheresis Outcome and Practice Patterns Study

Therapeutic apheresis and dialysis, 2023-02, Vol.27 (1), p.123-135

2023

Volltextzugriff (PDF)

A clinical predictive score for postoperative myasthenic crisis

Annals of neurology, 2017-11, Vol.82 (5), p.841-849

2017

Volltextzugriff (PDF)

Vertebral Artery Stump Syndrome

Internal Medicine, 2018/03/01, Vol.57(5), pp.733-736

2018

Volltextzugriff (PDF)

Dynamic planar scintigraphy for the rapid kinetic measurement of myocardial 123I-MIBG turnover can identify Lewy body disease

EJNMMI research, 2021-12, Vol.11 (1), p.122-122, Article 122

2021

Volltextzugriff (PDF)

Hilary and Jackie: A Genius Cellist and Multiple Sclerosis

Brain and nerve = Shinkei kenkyū no shinpo, 2022-12, Vol.74 (12), p.1395

Oji, Satoru

2022

Volltextzugriff (PDF)

Experimental Neuromyelitis Optica Induces a Type I Interferon Signature in the Spinal Cord

PloS one, 2016-03, Vol.11 (3), p.e0151244-e0151244

2016

Volltextzugriff (PDF)

Quality of life in purely ocular myasthenia in Japan

BMC neurology, 2014-07, Vol.14 (1), p.142-142, Article 142

2014

Volltextzugriff (PDF)

Association between peripheral plasmablasts and postoperative exacerbation in patients with thymoma‐associated myasthenia gravis

Clinical & experimental neuroimmunology, 2019-05, Vol.10 (2), p.110-117

2019

Volltextzugriff (PDF)

Immunoadsorption in neurological disorders

Transfusion and apheresis science, 2017-10, Vol.56 (5), p.671-676

2017

Volltextzugriff (PDF)

Congress report of the 12th World Congress of International Society for Apheresis/40th Annual Meeting of Japanese Society for Apheresis in Kyoto: Apheresis for neurological diseases

Clinical & experimental neuroimmunology, 2020-02, Vol.11 (1), p.79-81

Oji, Satoru

2020

Volltextzugriff (PDF)

Guillain–Barré syndrome initially manifesting as motor weakness, urinary dysfunction and hyperreflexia: Case report and literature review

Clinical & experimental neuroimmunology, 2018-05, Vol.9 (2), p.110-114

2018

Volltextzugriff (PDF)

The accuracy of flow cytometric cell-based assay to detect anti-myelin oligodendrocyte glycoprotein (MOG) antibodies determining the optimal method for positivity judgement

Journal of neuroimmunology, 2019-11, Vol.336, p.577021-577021, Article 577021

2019

Volltextzugriff (PDF)

Clinical and immunological differences between MOG associated disease and anti AQP4 antibody-positive neuromyelitis optica spectrum disorders: Blood–brain barrier breakdown and peripheral plasmablasts

Multiple sclerosis and related disorders, 2020-06, Vol.41, p.102005-102005, Article 102005

2020

Volltextzugriff (PDF)

Mean Platelet Volume Is Associated with Early Neurological Deterioration in Patients with Branch Atheromatous Disease: Involvement of Platelet Activation

Journal of stroke and cerebrovascular diseases, 2018-06, Vol.27 (6), p.1624-1631

2018

Volltextzugriff (PDF)

Tacrolimus is effective for neuromyelitis optica spectrum disorders with or without anti-AQP4 antibody

Multiple sclerosis and related disorders, 2020-04, Vol.39, p.101907-101907, Article 101907

2020

Volltextzugriff (PDF)

The Japanese Society for Apheresis clinical practice guideline for therapeutic apheresis

Therapeutic apheresis and dialysis, 2021-12, Vol.25 (6), p.728-876

2021

Volltextzugriff (PDF)

Dynamic planar scintigraphy for the rapid kinetic measurement of myocardial 123 I-MIBG turnover can identify Lewy body disease

EJNMMI research, 2021-12, Vol.11 (1), p.122

2021

Volltextzugriff (PDF)

Quotient of cerebrospinal fluid/serum immunoglobulin G as a predictive factor for non-responders to intravenous methylprednisolone therapy in patients with relapsing neuromyelitis optica spectrum disorder: Implication for early initiation of plasmapheresis

Clinical & experimental neuroimmunology, 2016-08, Vol.7 (3), p.272-280

2016

Volltextzugriff (PDF)

Experimental Neuromyelitis Optica Induces a Type I Interferon Signature in the Spinal Cord: e0151244

PloS one, 2016-03, Vol.11 (3)

2016

Volltextzugriff (PDF)

Phosphorus Electrodes in Sodium Cells: Small Volume Expansion by Sodiation and the Surface‐Stabilization Mechanism in Aprotic Solvent

ChemElectroChem, 2014-03, Vol.1 (3), p.580-589

2014

Volltextzugriff (PDF)

Enhanced immune reaction resulting from co-vaccination of WT1 helper peptide assessed on PET-CT

Medicine (Baltimore), 2020-09, Vol.99 (39), p.e22417-e22417

2020

Volltextzugriff (PDF)

Mice with Calr mutations homologous to human CALR mutations only exhibit mild thrombocytosis

Blood cancer journal (New York), 2019-03, Vol.9 (4), p.42-42, Article 42

2019

Volltextzugriff (PDF)

Wilms tumor gene (WT1) peptide-based cancer vaccine combined with gemcitabine for patients with advanced pancreatic cancer

Journal of immunotherapy (1997), 2014-02, Vol.37 (2), p.105

2014

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(24)

Sprache

Englisch
(23)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Science & Technology
(16)
Life Sciences & Biomedicine
(14)
Humans
(12)
Female
(6)
Male
(6)
Neurosciences & Neurology
(6)
Middle Aged
(5)
Patients
(5)
Clinical Neurology
(4)
Hematology
(4)
Adult
(3)
Aged
(3)
Diagnosis
(3)
Japan
(3)
Myasthenia Gravis
(3)
Neuromyelitis Optica Spectrum Disorders
(3)
Neurosciences
(3)
Oncology
(3)
Plasmapheresis
(3)
Animals
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Real‐world application of plasmapheresis for neurological disease: Results from the Japan‐Plasmapheresis Outcome and Practice Patterns Study

A clinical predictive score for postoperative myasthenic crisis

Vertebral Artery Stump Syndrome

Dynamic planar scintigraphy for the rapid kinetic measurement of myocardial 123I-MIBG turnover can identify Lewy body disease

Nationwide Laboratory Surveillance of Progressive Multifocal Leukoencephalopathy in Japan: Fiscal Years 2011-2020

Hilary and Jackie: A Genius Cellist and Multiple Sclerosis

Experimental Neuromyelitis Optica Induces a Type I Interferon Signature in the Spinal Cord

Quality of life in purely ocular myasthenia in Japan

Association between peripheral plasmablasts and postoperative exacerbation in patients with thymoma‐associated myasthenia gravis

Immunoadsorption in neurological disorders

Congress report of the 12th World Congress of International Society for Apheresis/40th Annual Meeting of Japanese Society for Apheresis in Kyoto: Apheresis for neurological diseases

Guillain–Barré syndrome initially manifesting as motor weakness, urinary dysfunction and hyperreflexia: Case report and literature review

The accuracy of flow cytometric cell-based assay to detect anti-myelin oligodendrocyte glycoprotein (MOG) antibodies determining the optimal method for positivity judgement

Clinical and immunological differences between MOG associated disease and anti AQP4 antibody-positive neuromyelitis optica spectrum disorders: Blood–brain barrier breakdown and peripheral plasmablasts

Mean Platelet Volume Is Associated with Early Neurological Deterioration in Patients with Branch Atheromatous Disease: Involvement of Platelet Activation

Tacrolimus is effective for neuromyelitis optica spectrum disorders with or without anti-AQP4 antibody

The Japanese Society for Apheresis clinical practice guideline for therapeutic apheresis

Dynamic planar scintigraphy for the rapid kinetic measurement of myocardial 123 I-MIBG turnover can identify Lewy body disease

Quotient of cerebrospinal fluid/serum immunoglobulin G as a predictive factor for non-responders to intravenous methylprednisolone therapy in patients with relapsing neuromyelitis optica spectrum disorder: Implication for early initiation of plasmapheresis

Experimental Neuromyelitis Optica Induces a Type I Interferon Signature in the Spinal Cord: e0151244

Phosphorus Electrodes in Sodium Cells: Small Volume Expansion by Sodiation and the Surface‐Stabilization Mechanism in Aprotic Solvent

Enhanced immune reaction resulting from co-vaccination of WT1 helper peptide assessed on PET-CT

Mice with Calr mutations homologous to human CALR mutations only exhibit mild thrombocytosis

Wilms tumor gene (WT1) peptide-based cancer vaccine combined with gemcitabine for patients with advanced pancreatic cancer

Suchergebnisse filtern